Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss

Chen Kan; Jiazhao Yang; Haitao Fan; Yuanjuan Dai; Xingxing Wang; Rui Chen; Jia Liu; Xiangyue Meng; Wei Wang; Guiling Li; Jiao Zhou; Ya Zhang; Wanbo Zhu; Shiyuan Fang; Haiming Wei; Hong Zheng; Siying Wang; Fang Ni

doi:10.1038/s41413-022-00238-5

Bone Research ›› 2022, Vol. 10 ›› Issue (1) :64 DOI: 10.1038/s41413-022-00238-5

Correction

Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss

Author information +

History +

PDF

Cite this article

Download citation ▾

Chen Kan, Jiazhao Yang, Haitao Fan, Yuanjuan Dai, Xingxing Wang, Rui Chen, Jia Liu, Xiangyue Meng, Wei Wang, Guiling Li, Jiao Zhou, Ya Zhang, Wanbo Zhu, Shiyuan Fang, Haiming Wei, Hong Zheng, Siying Wang, Fang Ni. Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss. Bone Research, 2022, 10(1): 64 DOI:10.1038/s41413-022-00238-5

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Kan C et al. Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss. Bone Res., 2022, 10: 62